EquitiesResearch.com
by Date:
by Stock Symbols:
Symbol Search:

RDEA
4/24/2012

Ardea Biosciences, Inc. (NASDAQ:RDEA) announced yesterday it will be acquired for $32.00 a share by AstraZeneca (NYSE: AZN). Stockdiagnostics upgraded RDEA @ $3.35 on February 27,2006 after the company reported 4th quarter financials for the period ending December 31,2005. Since the upgrade 6 years ago shares have appreciated 855%.
<click to RDEA Stockdiagnostics OPS chart
<click to RDEA Stockdiagnostics OPS chart 5 year
<click to RDEA GFNN news story 7
<click to RDEA GFNN news story 3
<click to AZN Stockdiagnostics OPS chart